[1]
S. . Hosagowdar and M. G. . Kinkar, “PHARMACOVIGILANCE AND ADVERSE EVENT REPORTING IN CLINICAL TRIALS: BEST PRACTICES”, EJMMP, vol. 3, no. 10, pp. 18–27, Oct. 2023.